112 related articles for article (PubMed ID: 19874398)
1. POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.
Yoshioka N; Suzuki N; Uekawa A; Kiguchi K; Ishizuka B
Hum Cell; 2009 Nov; 22(4):94-100. PubMed ID: 19874398
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor POU6F1 is important for proliferation of clear cell adenocarcinoma of the ovary and is a potential new molecular target.
Suzuki N; Yoshioka N; Uekawa A; Matsumura N; Tozawa A; Koike J; Konishi I; Kiguchi K; Ishizuka B
Int J Gynecol Cancer; 2010 Feb; 20(2):212-9. PubMed ID: 20134265
[TBL] [Abstract][Full Text] [Related]
3. Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.
Suzuki N; Higashiguchi A; Hasegawa Y; Matsumoto H; Oie S; Orikawa K; Ezawa S; Susumu N; Miyashita K; Aoki D
Hum Cell; 2005 Sep; 18(3):147-55. PubMed ID: 17022147
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.
Aoki D; Suzuki N; Susumu N; Noda T; Suzuki A; Tamada Y; Higashiguchi A; Oie S; Nozawa S
Hum Cell; 2005 Sep; 18(3):143-6. PubMed ID: 17022146
[TBL] [Abstract][Full Text] [Related]
5.
Kawahara N; Yamada Y; Kobayashi H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070839
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
[TBL] [Abstract][Full Text] [Related]
7. Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.
Nomura H; Tamada Y; Miyagi T; Suzuki A; Taira M; Suzuki N; Susumu N; Irimura T; Aoki D
Oncol Res; 2006; 16(6):289-97. PubMed ID: 17476974
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy.
Matsuura M; Suzuki T; Saito T
Cancer Sci; 2010 Aug; 101(8):1828-33. PubMed ID: 20545695
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Itamochi H; Kigawa J; Sultana H; Iba T; Akeshima R; Kamazawa S; Kanamori Y; Terakawa N
Jpn J Cancer Res; 2002 Jun; 93(6):723-8. PubMed ID: 12079522
[TBL] [Abstract][Full Text] [Related]
10. Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer.
Nakazato T; Kanuma T; Tamura T; Faried LS; Aoki H; Minegishi T
Int J Gynecol Cancer; 2007; 17(2):426-32. PubMed ID: 17309563
[TBL] [Abstract][Full Text] [Related]
11. A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.
Suzuki N; Aoki D; Oie S; Horiuchi M; Hasegawa Y; Ezawa S; Suzuki A; Susumu N; Hosoi F; Kitazato K; Nozawa S
Gynecol Oncol; 2004 Sep; 94(3):643-9. PubMed ID: 15350353
[TBL] [Abstract][Full Text] [Related]
12. Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma.
Saga Y; Ohwada M; Suzuki M; Konno R; Kigawa J; Ueno S; Mano H
Oncol Rep; 2008 Dec; 20(6):1299-303. PubMed ID: 19020706
[TBL] [Abstract][Full Text] [Related]
13. Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells.
Gao S; Liu Q; Wang X; Lin B; Zhang S
Med Oncol; 2010 Sep; 27(3):960-7. PubMed ID: 19771531
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of pim-3 promotes proliferation and migration of ovarian cancer cells.
Zhuang H; Zhao MY; Hei KW; Yang BC; Sun L; Du X; Li YM
Asian Pac J Cancer Prev; 2015; 16(8):3325-31. PubMed ID: 25921139
[TBL] [Abstract][Full Text] [Related]
15. Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer.
Ota K; Ito K; Akahira J; Sato N; Onogawa T; Moriya T; Unno M; Abe T; Niikura H; Takano T; Yaegashi N
Int J Gynecol Pathol; 2007 Jul; 26(3):334-40. PubMed ID: 17581421
[TBL] [Abstract][Full Text] [Related]
16. Selection of human ovarian carcinoma cells with high dissemination potential by repeated passage of the cells in vivo into nude mice, and involvement of Le(x)-determinant in the dissemination potential.
Kiguchi K; Iwamori M; Mochizuki Y; Kishikawa T; Tsukazaki K; Saga M; Amemiya A; Nozawa S
Jpn J Cancer Res; 1998 Sep; 89(9):923-32. PubMed ID: 9818028
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
[TBL] [Abstract][Full Text] [Related]
18. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail.
Ding JX; Feng YJ; Yao LQ; Yu M; Jin HY; Yin LH
Gynecol Oncol; 2006 Nov; 103(2):623-30. PubMed ID: 16806441
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor 2 expression may be involved in transformation of ovarian endometrioma to clear cell carcinoma of the ovary.
Taniguchi F; Itamochi H; Harada T; Terakawa N
Int J Gynecol Cancer; 2013 Jun; 23(5):791-6. PubMed ID: 23640291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
